Biotech stocks get a boost, or plunge, as new clinical data is shared before major cancer meeting By: MarketWatch May 27, 2022 at 09:57 AM EDT This includes Arcellx, Iovance Biotherapeutics, and ZymeWorks. Read More >> Related Stocks: 4D Molecular Therapeutics, Inc. - Common Stock Amgen Arcellx, Inc. - Common Stock GSK plc American Depositary Shares (Each representing two Ordinary Shares) Iovance Biotherapeutics, Inc. - Common Stock Mirati Therapeutics, Inc. - Common Stock SPDR Series Trust SPDR S&P Biotech ETF SpringWorks Therapeutics, Inc. - common stock Zymeworks Inc. - Common Stock
